Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever

Hala M Lofty1, Huda Marzouk1, Yomna Farag1

  • 1Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.

Insights

Serum amyloid A (SAA) levels remain elevated in most Egyptian children with familial Mediterranean fever (FMF) even after attacks. This suggests ongoing subclinical inflammation, making SAA a potential marker for monitoring FMF activity.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Immunology

Background:

  • Serum amyloid A (SAA) is an acute-phase reactant associated with inflammatory conditions like familial Mediterranean fever (FMF).
  • Elevated SAA levels may correlate with an increased risk of developing amyloidosis.
  • Understanding SAA levels in pediatric FMF is crucial for monitoring disease activity and potential complications.

Purpose of the Study:

  • To measure serum amyloid A (SAA) levels in Egyptian children diagnosed with familial Mediterranean fever (FMF).
  • To investigate potential correlations between SAA levels and demographic factors or clinical manifestations in pediatric FMF patients.
  • To explore the relationship between SAA levels and specific genetic variants or colchicine adherence in FMF.

Main Methods:

  • The study included seventy-one Egyptian children diagnosed with familial Mediterranean fever (FMF).
  • Serum amyloid A (SAA) levels were measured in all participants.
  • Demographic data, clinical manifestations, genetic variants (V726A, M694V), and colchicine adherence were assessed.

Main Results:

  • A high SAA level was observed in 78.9% of the studied pediatric FMF patients, with a mean level of 81.62 ± 31.6 mg/L.
  • No significant correlation was found between SAA levels and demographic data or clinical symptoms.
  • Elevated SAA levels were more frequent in patients with the V726A allele and those with low adherence to colchicine therapy.

Conclusions:

  • High serum amyloid A (SAA) levels are prevalent in Egyptian children with familial Mediterranean fever (FMF), persisting even two weeks post-attack.
  • This suggests the presence of subclinical inflammation during attack-free periods in pediatric FMF.
  • SAA may serve as a valuable biomarker for detecting and monitoring ongoing inflammation in FMF patients, particularly in the pediatric population.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
548
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
395
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
289
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
848